REGEN COV bamlanivimab and etesevimab distribution currently halted due to high frequency of nonsusceptible variants ASPR announcement

Submitted by vgreene on Mon, 05/16/2022 - 19:07
Detail (Long)
REGEN-COV, bamlanivimab and etesevimab distribution currently halted due to high frequency of nonsusceptible variants (<a href=https://aspr.hhs.gov/COVID-19/Therapeutics/updates/Pages/important-update-24January2022.aspx><b><u>ASPR announcement</u></b></a>)